Daily Bulletin

Men's Weekly

.

Octapharma AG: Final data from the NuProtect study published on the immunogenicity of Nuwiq® in previously untreated patients with severe haemophilia A

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Octapharma AG: Final data from the NuProtect study published on the immunogenicity of Nuwiq® in previously untreated patients with severe haemophilia A

LACHEN, Switzerland, Feb. 23, 2021 /PRNewswire/ -- Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated patients (PUPs) with severe haemophilia A have been published in the leading medical journal Thrombosis and Haemostasis (Liesner RJ et al. "Simoctocog Alfa (Nuwiq&r...

Read more: Octapharma AG: Final data from the NuProtect study published on the immunogenicity of Nuwiq® in...

Business News

The ultimate checklist for launching a digital-first business

If you’re launching a business in 2025, chances are it’s going to be digital-first. Whether you’re running an online store, offering consulting services, or building something entirely new, they all h...

Daily Bulletin - avatar Daily Bulletin

“SMBs Are Building the Future While Australia Sleeps” — Marc Degli on AI, Innovation, and What Needs to Change

Australia’s startup scene has been called “emerging” for a decade — but for many founders, it still feels stalled. Government funding is mired in bureaucracy. Investors hedge their bets on “safe” deal...

Daily Bulletin - avatar Daily Bulletin

Hydrogen Pipe Infrastructure: A Guide to Future Networks

As Australia moves towards a cleaner energy future, hydrogen is emerging as a key player. But how do we get this promising energy source from production facilities to where it's needed? The answer l...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals